Study snapshot
- Published
- 2025-01-07
- Study design
- Four-arm randomized controlled trial with MRI-measured visceral adipose tissue
- Population
- Adults with overweight or obesity in Spain; 49 assigned to usual care, 49 early, 52 late and 47 self-selected time-restricted eating
- Sample size
- 197
- Duration
- 12 weeks
- Peer reviewed
- Yes
- Main reported result
- None of the three eight-hour eating windows added a detectable visceral-fat benefit beyond Mediterranean-diet usual care over 12 weeks.
- Reported effect
- Versus usual care: early -4% (95% CI -12 to 4), late -6% (95% CI -13 to 2), and self-selected -3% (95% CI -11 to 5); all were nonsignificant.
- Important limitations
-
- All groups received healthy-diet education; there was no untreated comparison.
- Twelve weeks cannot answer long-term adherence or disease outcomes.
- Some secondary weight or subcutaneous-fat outcomes differed even though the primary visceral-fat outcome did not.
- Results may not generalize beyond the Spanish cohort.
- Funding
- Spanish and European public research grants and the US National Institute on Aging intramural program.
- Conflicts of interest
- One author reported unrelated lecture fees from Novo Nordisk and Abbott; the other authors declared no competing interests.
How this article was sourced
Selected from a date-audited 500-paper PubMed screening ledger, then checked against the primary paper record and supporting research before drafting.
This page explains one recent research result in context. It does not turn a study average, biomarker, or association into an individual diagnosis, treatment promise, or personal forecast.
Three fasting clocks faced the same control
Researchers in Spain randomized 197 adults with overweight or obesity to four groups: 49 received usual care, 49 followed an early eight-hour eating window, 52 followed a late window and 47 selected their own window. All groups received Mediterranean-diet education, so the trial tested what timing added to an active healthy-diet comparison.
The primary outcome was visceral adipose tissue measured by MRI after 12 weeks. That choice raises the evidentiary bar above a tape measure or self-reported weight. Visceral fat is biologically relevant, but it is still an intermediate imaging outcome rather than a cardiovascular event or diabetes diagnosis.
Every confidence interval crossed zero
Compared with usual care, the early window produced a mean visceral-fat difference of -4%, with a 95% confidence interval from -12% to 4%. The late window produced -6%, with an interval from -13% to 2%. The self-selected window produced -3%, with an interval from -11% to 5%.
All three intervals include zero, meaning the data remain compatible with no added effect. The p values were 0.87 for early, 0.31 for late and at least 0.99 for self-selected timing versus usual care. The negative point estimates should not be described as proven losses merely because their signs lean in the hoped-for direction.
View accessible chart data
| Group or point | Value | Lower bound | Upper bound | Note |
|---|---|---|---|---|
| Early window | -4 % mean difference | -12 % mean difference | 4 % mean difference | p=0.87 |
| Late window | -6 % mean difference | -13 % mean difference | 2 % mean difference | p=0.31 |
| Self-selected window | -3 % mean difference | -11 % mean difference | 5 % mean difference | p>=0.99 |
High adherence makes the null harder to dismiss
Adherence ranged from 85% to 88% across the time-restricted groups. That does not guarantee perfect measurement, but it weakens the easy explanation that the intervention failed only because participants ignored it. People largely followed the assigned clocks, yet MRI did not detect a clear additional visceral-fat reduction.
A well-conducted null result can prevent wasted optimization. The trial does not support choosing breakfast-only, evening or self-selected timing on the promise that one will specifically melt more visceral fat than Mediterranean-diet usual care over 12 weeks. Preference and schedule may still matter for adherence or other outcomes.
Secondary changes do not rewrite the primary result
Some secondary weight or subcutaneous-fat outcomes differed even though the primary visceral-fat comparison did not. Those signals can be reported as secondary findings, but they cannot be promoted into evidence that the trial's main hypothesis succeeded. Prespecified outcome hierarchy protects readers from choosing whichever measurement looks most favorable after results arrive.
Related randomized work has found no broad cardiometabolic improvement from intended isocaloric time restriction in women with overweight. A 12-month follow-up has examined weight-loss maintenance, and another trial has explored liver health and microbiota. Each extends a different endpoint; none turns the 12-week MRI null into a positive visceral-fat finding.
The follow-up evidence is particularly useful because a short intervention and long-term maintenance are separate tests. A schedule can be easy for 12 weeks and difficult for a year, or it can help body weight without changing the specific visceral depot. Outcome names and time horizons should stay visible whenever fasting trials are compared.
What remains after the best clock disappears
People may prefer a shorter eating window because it simplifies decisions, fits appetite or reduces opportunities to snack. This study neither confirms nor rejects those personal benefits. It addresses a narrower promise: an eight-hour clock, whether early, late or chosen, did not add a detectable MRI visceral-fat advantage to the healthy-diet control.
Spanish, European and US public programs funded the work. One author reported unrelated Novo Nordisk and Abbott lecture fees; the others declared no competing interests. Longer follow-up may clarify maintenance and other outcomes, but the present conclusion needs no rescue: the null primary result is useful evidence against selling one fasting clock as a visceral-fat shortcut.
A future study could identify response subgroups only if those analyses are planned and adequately powered. This trial does not supply a winning subgroup or a basis for tailoring the clock to produce more visceral-fat loss. For now, choosing a window is a preference decision rather than an evidence-based visceral-fat optimization.
The MRI endpoint deserves emphasis precisely because it resisted a simple story. Direct imaging can overturn assumptions built from body weight alone, and a credible null is part of scientific progress rather than empty space.